Difference between revisions of "RAYNAUD PHENOMENON-INVESTIGATION & MANAGEMENT"

From NeuroRehab.wiki

(Imported from text file)
(Imported from text file)
 
Line 8: Line 8:
<br/>4. Treatment includes: calcium channel blockers, alpha-blockers, sildenafil, and nitroglycerin transdermal.
<br/>4. Treatment includes: calcium channel blockers, alpha-blockers, sildenafil, and nitroglycerin transdermal.
<br/>
<br/>
<br/>5. Localized digital sympathectomy - for patients who have failed medical treatment &amp; continue to experience ischemia/necrosis.
<br/>5. Localized digital sympathectomy: for patients who have failed medical treatment &amp; continue to experience ischemia/necrosis.





Latest revision as of 11:07, 20 March 2023

SUMMARY

1. An easy test to distinguish primary from secondary Raynaud's is nailfold capillaroscopy.

2. Avoid the cold and drugs that cause vasoconstriction.

3. Smoking/tobacco use is contraindicated.

4. Treatment includes: calcium channel blockers, alpha-blockers, sildenafil, and nitroglycerin transdermal.

5. Localized digital sympathectomy: for patients who have failed medical treatment & continue to experience ischemia/necrosis.


Reference(s)

Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].